Cost-effectiveness of a telemonitoring programme in patients with cardiovascular diseases compared with standard of care.

Andreas Ziegler Alper Öner Gisela Quadflieg Raphael O BetschartAlexandre ThiéryHugo Babel Henry G MwambiHenriette NeumeyerSteffen MackschinSissy HintzMiriam MannHermann DittrichChristian Schmidt

Published in: Heart (British Cardiac Society) (2023)

NICC was associated with higher QoL and health utility. The programme is cost-effective if one is willing to pay approximately €11 000 per QALY per year.

Keyphrases

healthcare
cardiovascular disease
study protocol
public health
palliative care
health insurance
mental health
quality improvement
randomized controlled trial
affordable care act
risk assessment
type diabetes
pain management
climate change
clinical trial
metabolic syndrome